[ad_1]
SEATTLE, Aug. 9, 2022 /PRNewswire/ — According to Coherent Market Insightsthe global tissue engineering market is estimated to be valued at US$ 9,436.0 million in 2022 and is expected to exhibit a CAGR of 11.7% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Tissue Engineering Market:
Major players operating in the market are focusing on adopting growth strategies such as new product launch and approvals which is expected to drive the market growth over the forecast period. For instance, in June 2021, Mallinckrodt plc, a global biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns).
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2217
Key Market Takeaways:
The global tissue engineering market is expected to exhibit a CAGR of 11.7% during the forecast period due to technological advancements in 3D bio-printing, and potential pipeline products as 3D bioprinting is a rapidly developing industry used for a …
Full story available on Benzinga.com
[ad_2]
Source link
